Variant report
Variant | esv3477418 |
---|---|
Chromosome Location | chr7:100326216-100331314 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:183)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:100328040-100328372 | HepG2 | liver: | n/a | chr7:100328193-100328204 |
2 | CEBPB | chr7:100328044-100328375 | HepG2 | liver: | n/a | chr7:100328193-100328204 |
3 | CEBPB | chr7:100328099-100328290 | IMR90 | lung: | n/a | chr7:100328193-100328204 |
4 | CEBPB | chr7:100328048-100328277 | K562 | blood: | n/a | chr7:100328193-100328204 |
5 | CEBPB | chr7:100328137-100328308 | Hela-S3 | cervix: | n/a | chr7:100328193-100328204 |
6 | CEBPB | chr7:100328148-100328292 | A549 | lung: | n/a | chr7:100328193-100328204 |
7 | CEBPD | chr7:100328091-100328340 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr7:100329480-100329513 | GM13976 | blood: | n/a | n/a |
9 | FAM48A | chr7:100328354-100328449 | GM12878 | blood: | n/a | n/a |
10 | PAX5 | chr7:100329892-100330334 | GM12891 | blood: | n/a | n/a |
11 | POLR2A | chr7:100329493-100329614 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | POLR2A | chr7:100329481-100329606 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | SP1 | chr7:100329335-100329646 | HepG2 | liver: | n/a | n/a |
14 | ZBTB7A | chr7:100328037-100328215 | HepG2 | liver: | n/a | n/a |
15 | ZNF384 | chr7:100330766-100330914 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:100330587-100330637 | HMEC | breast: | n/a |
2 | chr7:100330587-100330637 | AG04450 | lung: | fetal |
3 | chr7:100330109-100330159 | BE2_C | brain: | n/a |
4 | chr7:100330587-100330637 | PFSK-1 | brain: | n/a |
5 | chr7:100330109-100330159 | GM12891 | blood: | n/a |
6 | chr7:100330872-100330922 | GM19239 | blood: | n/a |
7 | chr7:100330872-100330922 | HIPEpiC | eye: | n/a |
8 | chr7:100330587-100330637 | Caco-2 | colon: | n/a |
9 | chr7:100330587-100330637 | ovcar-3 | ovarian: | n/a |
10 | chr7:100330587-100330637 | HCM | heart: | n/a |
11 | chr7:100330109-100330159 | HNPCEpiC | eye: | n/a |
12 | chr7:100330109-100330159 | ovcar-3 | ovarian: | n/a |
13 | chr7:100330109-100330159 | HL-60 | blood: | n/a |
14 | chr7:100330109-100330159 | GM19239 | blood: | n/a |
15 | chr7:100330587-100330637 | HCPEpiC | choroid plexus: | n/a |
16 | chr7:100330587-100330637 | HEEpiC | esophagus: | n/a |
17 | chr7:100330587-100330637 | T-47D | breast: | n/a |
18 | chr7:100330109-100330159 | AG09319 | gingival: | n/a |
19 | chr7:100330872-100330922 | HEEpiC | esophagus: | n/a |
20 | chr7:100330109-100330159 | HRCEpiC | kidney: | n/a |
21 | chr7:100330587-100330637 | MCF10A-Er-Src | breast: | n/a |
22 | chr7:100330587-100330637 | HRE | kidney: | n/a |
23 | chr7:100330587-100330637 | HUVEC | blood vessel: | n/a |
24 | chr7:100330872-100330922 | MCF10A-Er-Src | breast: | n/a |
25 | chr7:100330587-100330637 | IMR90 | lung: | fetal |
26 | chr7:100330587-100330637 | HEK293 | kidney: | embryo |
27 | chr7:100330109-100330159 | SKMC | muscle: | n/a |
28 | chr7:100330109-100330159 | AG10803 | skin: | n/a |
29 | chr7:100330872-100330922 | A549 | lung: | n/a |
30 | chr7:100330872-100330922 | GM12878 | blood: | n/a |
31 | chr7:100330109-100330159 | SK-N-SH_RA | brain: | n/a |
32 | chr7:100330587-100330637 | GM12878 | blood: | n/a |
33 | chr7:100330587-100330637 | HL-60 | blood: | n/a |
34 | chr7:100330109-100330159 | ECC-1 | luminal epithelium: | n/a |
35 | chr7:100330109-100330159 | LNCaP | prostate: | n/a |
36 | chr7:100330587-100330637 | HPAEpiC | pulmonary alveolar: | n/a |
37 | chr7:100330872-100330922 | SAEC | small airway: | n/a |
38 | chr7:100330872-100330922 | H1-hESC | embryonic stem cell: | embryo |
39 | chr7:100330109-100330159 | CMK | blood: | n/a |
40 | chr7:100330587-100330637 | Hela-S3 | cervix: | n/a |
41 | chr7:100330109-100330159 | HepG2 | liver: | n/a |
42 | chr7:100330872-100330922 | ovcar-3 | ovarian: | n/a |
43 | chr7:100330587-100330637 | LNCaP | prostate: | n/a |
44 | chr7:100330109-100330159 | SK-N-SH | brain: | n/a |
45 | chr7:100330872-100330922 | HepG2 | liver: | n/a |
46 | chr7:100330872-100330922 | NH-A | brain: | n/a |
47 | chr7:100330872-100330922 | AG04450 | lung: | fetal |
48 | chr7:100330587-100330637 | U87 | brain: | n/a |
49 | chr7:100330872-100330922 | Hepatocyte | liver: | n/a |
50 | chr7:100330587-100330637 | SK-N-SH | brain: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:100181969..100184766-chr7:100322000..100326304,4 | MCF-7 | breast: | |
2 | chr7:100326112..100327796-chr7:100392464..100395372,2 | MCF-7 | breast: | |
3 | chr7:100317007..100319008-chr7:100325168..100326733,2 | K562 | blood: | |
4 | chr7:100325203..100328007-chr7:100356386..100357913,2 | K562 | blood: | |
5 | chr7:100324153..100326301-chr7:100361628..100364421,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZAN | TF binding region |
ZAN | CpG island |
ENSG00000130427 | chromatin interactions |
ENSG00000106336 | chromatin interactions |
ENSG00000077454 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531213259 | chr7:100326222-100326223 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs374962131 | chr7:100326238-100326239 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs546213353 | chr7:100326267-100326268 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs116584510 | chr7:100326273-100326274 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs74299683 | chr7:100326315-100326316 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs56394908 | chr7:100326356-100326357 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs547220058 | chr7:100326370-100326371 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs568527160 | chr7:100326371-100326372 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs529448777 | chr7:100326372-100326373 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs550994773 | chr7:100326377-100326378 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs368690388 | chr7:100326381-100326382 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs570725176 | chr7:100326383-100326384 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs190556224 | chr7:100326407-100326408 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs552154968 | chr7:100326408-100326409 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs570726284 | chr7:100326455-100326456 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs534475917 | chr7:100326469-100326470 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs139912009 | chr7:100326478-100326479 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs149895564 | chr7:100326534-100326535 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs535201844 | chr7:100326567-100326568 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs556523710 | chr7:100326587-100326588 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs371047784 | chr7:100326743-100326744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4729607 | chr7:100326744-100326745 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs182314993 | chr7:100326762-100326763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536141364 | chr7:100326778-100326779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556977835 | chr7:100326802-100326803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143956239 | chr7:100326834-100326835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567370432 | chr7:100326845-100326846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184452973 | chr7:100326849-100326850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540820583 | chr7:100326995-100326996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562315327 | chr7:100327025-100327026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189332934 | chr7:100327073-100327074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4727462 | chr7:100327089-100327090 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs553187483 | chr7:100327101-100327102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143161009 | chr7:100327146-100327147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181321207 | chr7:100327151-100327152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13221242 | chr7:100327156-100327157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551760233 | chr7:100327168-100327169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146676917 | chr7:100327171-100327172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs199783394 | chr7:100327197-100327198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185541228 | chr7:100327328-100327329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572602593 | chr7:100327358-100327359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550281267 | chr7:100327362-100327363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190648199 | chr7:100327365-100327366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535282334 | chr7:100327377-100327378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554371956 | chr7:100327435-100327436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546138555 | chr7:100327445-100327446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139813080 | chr7:100327494-100327495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201579190 | chr7:100327496-100327497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545160898 | chr7:100327514-100327515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201020568 | chr7:100327515-100327516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 16608533 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Liver carcinoma | 19366792 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Breast cancer | 21858162 | CNVD |
Emphysema | 19352772 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 19401682 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 21509527 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Prostate cancer | 18632612 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:100319200-100342800 | Weak transcription | Right Atrium | heart |
2 | chr7:100322000-100326400 | Enhancers | HepG2 | liver |
3 | chr7:100323800-100326400 | Enhancers | HSMMtube | muscle |
4 | chr7:100323800-100328000 | Weak transcription | Hela-S3 | cervix |
5 | chr7:100323800-100334400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr7:100325400-100333000 | Weak transcription | Liver | Liver |
7 | chr7:100326400-100327800 | Weak transcription | HepG2 | liver |
8 | chr7:100327800-100328000 | Enhancers | HepG2 | liver |
9 | chr7:100327800-100328000 | Bivalent Enhancer | HSMMtube | muscle |
10 | chr7:100328000-100328200 | Enhancers | Hela-S3 | cervix |
11 | chr7:100328000-100328200 | Flanking Active TSS | HepG2 | liver |
12 | chr7:100328200-100328400 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr7:100328200-100328400 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr7:100328200-100328800 | Enhancers | HepG2 | liver |
15 | chr7:100328400-100328600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr7:100328800-100329200 | Weak transcription | HepG2 | liver |
17 | chr7:100329200-100334400 | Enhancers | HepG2 | liver |
18 | chr7:100329600-100331000 | Enhancers | Primary B cells from peripheral blood | blood |
19 | chr7:100329600-100331200 | Enhancers | Primary B cells from cord blood | blood |
20 | chr7:100329800-100330600 | Enhancers | GM12878-XiMat | blood |